Page last updated: 2024-12-06

belfosdil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

belfosdil: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72122
CHEMBL ID2103776
SCHEMBL ID122318
MeSH IDM0169635

Synonyms (24)

Synonym
103486-79-9
belfosdil (usan/inn)
D03067
belfosdil
[4-dibutoxyphosphoryl-3-(dibutoxyphosphorylmethyl)butoxy]benzene
CHEMBL2103776
belfosdilum
bmy-21891
bmy 21891
phosphonic acid, (2-(2-phenoxyethyl)-1,3-propanediyl)bis-, tetrabutyl ester
belfosdil [usan:inn]
unii-w91cms1v7z
sr 7037
sr-7037
w91cms1v7z ,
tetrabutyl (2-(2-phenoxyethyl)trimethylene)diphosphonate
belfosdilum [inn-latin]
tetrabutyl 2-(2-phenoxyethyl)-1,3-propylidene diphosphonate
belfosdil [inn]
belfosdil [usan]
SCHEMBL122318
DTXSID40869395
Q27292482
AKOS040747937
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's4 (66.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]